CONVERTING EORTC QOL-C30 SCORES TO UTILITY VALUES: IS IT PLAUSIBLE?

被引:0
|
作者
Salek, M. S. [1 ]
Schmidt-Rimpler, C. [2 ]
Wimberger, P. [3 ]
Gilet, H. [4 ]
Parsons, S. L. [5 ]
机构
[1] Cardiff Univ, Cardiff, S Glam, Wales
[2] Fresenius Biotech GmbH, Munich, Germany
[3] Univ Duisburg Essen, Essen, Germany
[4] MAPI Consultancy, Lyon, France
[5] Notthingham Univ Hosp NHS Trust, Nottingham, England
关键词
D O I
10.1016/j.jval.2012.08.1563
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A478 / A478
页数:1
相关论文
共 50 条
  • [1] Converting EORTC QLQ-C30 scores to utility scores in the brigatinib ALTA study
    Kawata, Ariane K.
    Lenderking, William R.
    Eseyin, Olabimpe R.
    Kerstein, David
    Huang, Joice
    Huang, Hui
    Zhang, Pingkuan
    Lin, Huamao M.
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (09) : 924 - 935
  • [2] CONVERTING EORTC QLQ-C30 SCORES TO EQ-5D UTILITY SCORES IN THE BRIGATINIB ALTA STUDY
    Kawata, A. K.
    Lenderking, W. R.
    Eseyin, O. R.
    Kerstein, D.
    Huang, J.
    Huang, H.
    Lin, H. M.
    VALUE IN HEALTH, 2018, 21 : S210 - S210
  • [3] ESTIMATING EORTC-8D HEALTH STATE UTILITY VALUES FROM EORTC QLQ-C30 SCORES IN RELAPSED MULTIPLE MYELOMA
    Ashaye, A. O.
    Altincatal, A.
    Bender, R. H.
    Zhang, J.
    Panjabi, S.
    VALUE IN HEALTH, 2015, 18 (07) : A468 - A468
  • [4] Derivation of utility values from EORTC QLQ-C30 values in lung cancer
    Jang, Raymond
    Isogai, Pierre K.
    Mittmann, Nicole
    Bradbury, Penelope A.
    Shepherd, Frances
    Feld, Ronald
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S420 - S421
  • [5] Summary scores captured changes in subjects' QoL as measured by the multiple scales of the EORTC QLQ-C30
    Phillips, Rachel
    Gandhi, Mihir
    Cheung, Yin Bun
    Findlay, Michael P.
    Win, Khin Maung
    Hai, Hoang Hoa
    Yang, Jin Mo
    Lobo, Rolley Rey
    Soo, Khee Chee
    Chow, Pierce K. H.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2015, 68 (08) : 895 - 902
  • [6] CONVERTING EORTC QLQ-C30 SCORES AND FACT-G SCORES TO ONE ANOTHER: FEASIBILITY AND RELIABILITY CONSIDERATIONS
    Kemmler, Georg W.
    Holzner, Bernhard
    Sperner-Unterweger, Barbara
    Cella, David
    QUALITY OF LIFE RESEARCH, 2004, 13 (09) : 1552 - 1552
  • [7] 循证护理在肿瘤化疗患者PICC管理中的应用及对EORTC QOL-C30评分的影响
    严玲
    中外医学研究, 2020, 18 (09) : 83 - 86
  • [8] Derivation of utility values from EORTC QLQC30 in lung cancer
    Jang, R. W.
    Mittmann, N.
    Isogai, P.
    Bradbury, P. A.
    Leighl, N. B.
    VALUE IN HEALTH, 2008, 11 (03) : A77 - A78
  • [9] MAPPING UTILITY SCORES FROM EUROPEAN ORGANIZATION FOR TREATMENT OF CANCER CORE-30 QUESTIONNAIRE SCORES (EORTC QLQ-C30) IN RELAPSED MULTIPLE MYELOMA
    Ashaye, A. O.
    Zhang, J.
    Bender, R. H.
    Altincatal, A.
    Panjabi, S.
    VALUE IN HEALTH, 2015, 18 (03) : A208 - A208
  • [10] Ordinal regression in the mapping of DLQI scores to EQ-5D utility values: is it plausible?
    Ali, F. M.
    Kay, R.
    Finlay, A. Y.
    Salek, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S39 - S39